PIMREG and endothelial dysfunction: However, we and others have previously shown that Cat-S inhibition also prevents Cat-S-mediated activation of PAR-2 on vascular endothelial cells and thereby attenuates endothelial dysfunction–related organ injury (Kumar et al., 2016).